Statements (27)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:hesperidin
diosmin |
| gptkbp:ATCCode |
C05CA53
|
| gptkbp:drugClass |
vasoprotective agent
venotonic |
| gptkbp:form |
gptkb:tablet
|
| https://www.w3.org/2000/01/rdf-schema#label |
Daflon
|
| gptkbp:legalStatus |
over-the-counter (in some countries)
prescription drug (in some countries) |
| gptkbp:manufacturer |
gptkb:Servier
|
| gptkbp:marketedIn |
gptkb:Asia
gptkb:Europe gptkb:Latin_America |
| gptkbp:mechanismOfAction |
improves venous tone
increases lymphatic drainage reduces capillary permeability |
| gptkbp:notRecommendedFor |
children
pregnant women (without medical advice) |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
gastrointestinal discomfort
headache skin rash |
| gptkbp:usedFor |
hemorrhoids
chronic venous insufficiency |
| gptkbp:bfsParent |
gptkb:Servier_Pharmaceuticals
|
| gptkbp:bfsLayer |
7
|